United States.. Urgent recall of thousands of blood pressure medication packages after detecting potential carcinogenic impurities
November 1, 2025368 ViewsRead Time: 2 minutes
Font Size
16
American company "Teva" announced the recall of more than 580,000 packages of the medication "Hydrochloride Prazosin" used to treat high blood pressure, after discovering impurities from "nitrosamine" compounds that are suspected of causing cancer.
The recall was conducted in collaboration with the distribution company "Amerisource", and the medication is primarily sold under the brand names "Minipress" and "Prazin", used by nearly half a million patients in the United States.
The company stated that the recall includes:
181,659 packages with a concentration of 1 mg
291,512 packages with a concentration of 2 mg
107,673 packages with a concentration of 5 mg
The U.S. Food and Drug Administration (FDA) classifies this recall as a Class II, meaning that the medication may cause temporary or reversible health issues, with a low likelihood of serious effects. No injuries or health problems related to the drug have been reported so far.
Research indicates that nitrosamine impurities may form during the manufacturing or storage of certain medications and food products, and may cause DNA damage according to studies conducted on animals, increasing the likelihood of liver, stomach, and lung tumors, but evidence of their human impact remains inconclusive.
Experts warned against abruptly stopping the intake of blood pressure medications from the alpha-1 blocker class, as this may lead to a sharp increase in blood pressure, chest pain, and rapid heartbeats, which increases the risks of heart attacks and strokes. They recommended consulting a doctor before stopping the medication or adjusting the dosage.
The recall was conducted in collaboration with the distribution company "Amerisource", and the medication is primarily sold under the brand names "Minipress" and "Prazin", used by nearly half a million patients in the United States.
The company stated that the recall includes:
181,659 packages with a concentration of 1 mg
291,512 packages with a concentration of 2 mg
107,673 packages with a concentration of 5 mg
The U.S. Food and Drug Administration (FDA) classifies this recall as a Class II, meaning that the medication may cause temporary or reversible health issues, with a low likelihood of serious effects. No injuries or health problems related to the drug have been reported so far.
Research indicates that nitrosamine impurities may form during the manufacturing or storage of certain medications and food products, and may cause DNA damage according to studies conducted on animals, increasing the likelihood of liver, stomach, and lung tumors, but evidence of their human impact remains inconclusive.
Experts warned against abruptly stopping the intake of blood pressure medications from the alpha-1 blocker class, as this may lead to a sharp increase in blood pressure, chest pain, and rapid heartbeats, which increases the risks of heart attacks and strokes. They recommended consulting a doctor before stopping the medication or adjusting the dosage.
